Black J L, Armour C L, Vincenc K S, Johnson P R
Prostaglandins. 1986 Jul;32(1):25-31. doi: 10.1016/0090-6980(86)90139-5.
Prostaglandins may be implicated in the bronchoconstriction which occurs in asthma. Prostaglandins F2 alpha (PGF2 alpha) and D2 (PGD2) have been reported to produce bronchoconstriction in asthmatic subjects in vivo and PGF2 alpha contracts human isolated airway smooth muscle. We examined the relative efficacy and potency of PGF2 alpha and PGD2 on human bronchial spiral strips taken from 6 patients at thoracotomy. PGF2 alpha had greater efficacy than PGD2. The mean % Tmax (percentage of maximal contractile response) +/- s.e. mean were 84 +/- 7 and 54 +/- 7 respectively (P less than 0.05). PGF2 alpha (mean pD2 +/- s.e. mean = 6.39 +/- 0.6) tended to be more potent than PGD2 (5.68 +/- 0.2). Since, in vivo, PGD2 has greater efficacy and potency than PGF2 alpha, our results suggest that the in vivo effect of these prostaglandins does not result solely from an action on airway muscle.
前列腺素可能与哮喘时发生的支气管收缩有关。据报道,前列腺素F2α(PGF2α)和D2(PGD2)在体内可使哮喘患者发生支气管收缩,且PGF2α可使人体离体气道平滑肌收缩。我们研究了PGF2α和PGD2对6例开胸手术患者的人支气管螺旋条的相对效力和效能。PGF2α的效力大于PGD2。平均最大收缩反应百分比(%Tmax)±标准误分别为84±7和54±7(P<0.05)。PGF2α(平均pD2±标准误=6.39±0.6)的效能倾向于比PGD2(5.68±0.2)更强。由于在体内PGD2的效力和效能大于PGF2α,我们的结果表明这些前列腺素的体内效应并非仅由对气道平滑肌的作用所致。